AcotiaMide Related CoMpound (Ethyl 2-[(2-hydroxy-4,5-diMethoxybenzoyl)aMino]-4-Thiazolecarboxylate) (185106-05-2)

Other Product

• ETHYL 2-DIMETHYLAMINO-4-TRIFLUOROMETHYL-5-THIAZOLECARBOXYLATE
• ETHYL 2-(4-CHLOROPHENYLAMINO)-4-THIAZOLECARBOXYLATE
• Ethyl 4-(4-Fluorophenyl)-2-thiazolecarboxylate
• Ethyl 4-(4-Pyridyl)-2-thiazolecarboxylate
• ETHYL 2-PHENYLAMINO-5-THIAZOLECARBOXYLATE
• Trimethoprim Related Compound A (25 mg) (4-amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-2-ol) (AS)
• Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol)
• Methyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate
• Pazopanib Related Compound 2
• Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone)
• Dantrolene Related Compound A (50 mg) (5-(4-nitrophenyl)-2-furaldehyde azine)
• Aripiprazole Related CoMpound (5-(4-broMobutoxy)-3,4-dihydroquinolin-2(1H)-one)
• REPAGLINIDE RELATED COMPOUND C (25 MG) ((S)-2-ETHOXY-4-[2-[[2-PHENYL-1 -[2-(1 -PIPERIDINYL)PHE-NYL]ETHYL]AMINO]-2-OXOETHYL] BENZOIC ACID)
• Benzoicacid,5-[(3,5-dimethoxybenzoyl)amino]-2-hydroxy-
• Levalbuterol Related Compound B (20 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol)
• Levalbuterol Related Compound C (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol)
• Benzoic acid,4-[(3,5-dimethoxybenzoyl)amino]-2-hydroxy-
• Copper(2+), bis[ethyl2-[(2-benzothiazolyl-kN3)methyl]-4-methyl-5-thiazolecarboxylate-kN3]-, dichloride (9CI)
• Anagrelide Related Compound A (25 mg) (ethyl 2-(6-amino-2,3-dichlorobenzylamino)acetate)
• ethyl 4-carbamoyl-5-[(3,5-dimethoxybenzoyl)amino]-3-methylthiophene-2-carboxylate